Browsing: drug

Kvantify has announced the launch of a revolutionary computational method designed to accelerate the early phases of drug discovery. This innovative approach is a significant enhancement to the company’s existing computational drug discovery platform, Koffee, and distinguishes itself from other solutions currently available in the market. According to Hans Henrik Knudsen, CEO of Kvantify, the new binding affinity tool stands out in performance, boasting benchmark tests that reveal it is 100 times faster than comparable state-of-the-art methods while maintaining the same level of accuracy. This tool plays a crucial role in drug discovery, as binding affinity refers to the strength…

AscellaHealth, a leading global partner in customisable solutions for the specialty pharmaceutical industry, has announced its role as Gold Sponsor of the upcoming World Orphan Drug Congress Europe (WODC). The event is scheduled to take place from 22nd to 25th October 2024 in Barcelona, Spain. The WODC is renowned as the largest and most established conference dedicated to orphan drugs and rare diseases worldwide. This annual gathering brings together industry leaders, healthcare professionals, and stakeholders to discuss advancements in orphan drug development and strategies for enhancing patient access to therapies. AscellaHealth will showcase its comprehensive suite of end-to-end solutions, designed…